Photo credit: J&J
My first encounter with Johnson & Johnson came as a child, when one of its shampoo brands made showers easier for a clumsy kid. But the company is also a healthcare giant whose products and technologies touch nearly every part of modern medicine. As its CEO, Joaquin Duato oversees a massive business that spans pharmaceuticals, medical devices, and innovation platforms that literally define how patients are treated around the world.
Right now, his influence is especially strong because J&J is doubling down on frontier medical advances, such as next-gen drug development, surgical robotics, and global health infrastructure. When Duato initiates investment or strategy shifts, it affects hospitals, insurers, researchers, and millions of patients. Few executives control a pipeline this large or a supply chain this global.
J&J’s scale also gives him a seat at policy tables when conversations turn to topics such as drug pricing, manufacturing, and preparedness for future health crises.
